All Featured Insights

Assessing the future of healthcare price transparency requires taking a couple of steps back to review its recent history.

The hospital and health system leaders we work with are extremely concerned about the financial impact their organizations may experience from potentially significant Medicaid policy changes, following the recent passage of a budget resolution by the U.S. House of Representatives.

HHS probationary workers fired, Hart-Scott-Rodino changes lead to deluge of premerger filings, the state of the flu response.

RFK Jr. clears Senate panel, federal and state policy battle over transgender care comes to head in New York, Moody’s downgrades health insurer credit outlook

Health plans interested in inorganic growth should reflect deeply to better understand their motivations as it relates to their strategic goals.

The future will favor payers that adapt to changing market circumstances with agency and velocity. Payers will need to make tough choices.

Following the release of Q3 financial reports, this week’s graphic takes stock of large health insurance companies’ recent financial performances.

CMS proposes adding weight-loss drugs to Medicare coverage, Trump nominates more healthcare positions, and a study tracks widespread pharmacy closures.

This week’s graphic highlights the increasing prominence of state-directed payment (SDP) arrangements for Medicaid programs nationwide.

Trump picks his healthcare cabinet nominees, PBMs sue the FTC over its insulin case, and controlled substance telehealth flexibilities are extended yet again.

DOJ sues to block UHG-Amedisys deal, Cigna quashes Humana merger talks, and Johnson & Johnson sues to revive its 340B rebate program.

The Medicare Advantage market has seen unprecedented growth in recent years, with a majority of Medicare eligible beneficiaries enrolling in one of these privately administered plans in...